Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(19 sites)
United States
Washington University Center for Advanced Medicine, St Louis, Missouri New York Presbyterian Hospital-Columbia University Medical Center, New York, New York Austria
Universitätsklinikum AKH Wien, Vienna, State of Vienna Denmark
Rigshospitalet-Blegdamsvej 9, Copenhagen France
AP-HP - Hôpital Beaujon, Clichy Germany
Universitätsmedizin Rostock, Rostock, Mecklenburg-Vorpommern Eugastro Klinische Studien GmbH, Leipzig, Saxony Charité - Universitätsmedizin Berlin, Berlin Universitätsklinikum Bonn, Bonn Asklepios Klinik St. Georg, Hamburg Italy
Fondazione Policlinico Universitario A. Gemelli IRCCS - PPDS, Rome, Lazio Netherlands
Radboud Universitair Medisch Centrum, Nijmegen, Gelderland Norway
Oslo Universitetssykehus HF, Ullevål, Oslo Poland
Wojewodzki Specjalistyczny Szpital im. M. Pirogowa w Lodzi, Lodz, Lódzkie Spain
Hospital General Universitario Gregorio Marañon, Madrid Hospital Universitario 12 de Octubre, Madrid Hospital Universitario Virgen del Rocio - PPDS, Seville Sweden
Sahlgrenska Universitets sjukhuset, Gothenburg Karolinska Universitetssjukhuset Solna, Solna